Dupont Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-8,616
| Closed | -$83K | – | 1471 |
|
|
2022
Q3 | $83K | Buy |
+8,616
| New | +$83K | ﹤0.01% | 1092 |
|
|
2021
Q1 | – | Sell |
-4,869
| Closed | -$226K | – | 1612 |
|
|
2020
Q4 | $226K | Hold |
4,869
| – | – | ﹤0.01% | 1113 |
|
|
2020
Q3 | $160K | Sell |
4,869
-14,758
| -75% | -$485K | ﹤0.01% | 1144 |
|
|
2020
Q2 | $539K | Sell |
19,627
-494
| -2% | -$13.6K | 0.01% | 744 |
|
|
2020
Q1 | $602K | Sell |
20,121
-5,352
| -21% | -$160K | 0.01% | 615 |
|
|
2019
Q4 | $705K | Buy |
+25,473
| New | +$705K | 0.02% | 687 |
|
|
2019
Q2 | – | Sell |
-37,870
| Closed | -$360K | – | 1235 |
|
|
2019
Q1 | $360K | Hold |
37,870
| – | – | 0.01% | 885 |
|
|
2018
Q4 | $335K | Buy |
37,870
+9,933
| +36% | +$87.9K | 0.01% | 883 |
|
|
2018
Q3 | $314K | Buy |
+27,937
| New | +$314K | 0.01% | 821 |
|